The final, formatted version of the article will be published soon.
SYSTEMATIC REVIEW article
Front. Neurol.
Sec. Cognitive and Behavioral Neurology
Volume 16 - 2025 |
doi: 10.3389/fneur.2025.1500667
This article is part of the Research Topic Innovations in the assessment and treatment of TBI and co-occurring conditions in military connected populations View all articles
Gene c and peripheral biomarkers of comorbid pos rauma c stress disorder and trauma c brain injury: a systema c review
Provisionally accepted- 1 Psychological Health Center of Excellence, Defense Health Agency, Silver Spring, United States
- 2 Traumatic Brain Injury Center of Excellence, Defense Health Agency, Silver Spring, United States
Background: Posttraumatic stress disorder (PTSD) commonly cooccurs with traumatic brain injury (TBI) in military populations and is a significant predictor of poor long-term outcomes; however, it is unclear to what extent specific biological variables are associated with comorbidity. This PROSPERO-registered systematic review evaluates the current body of literature on genetic and peripheral biomarkers associated with comorbid TBI and PTSD. Methods: Searches were conducted in four databases (PubMed, PsycInfo, PTSDPubs, Scopus). We included published studies examining differences in peripheral biomarkers among civilian, military, and veteran participants with both TBI and PTSD compared to those with TBI alone as well as, in some cases, PTSD alone and healthy controls. Data were extracted from included studies and evidence quality was assessed. Results: Our final analysis included 16 studies, the majority of which were based on data from active duty military and veteran participants. The results suggest that multiple gene variants are likely to contribute to the cumulative risk of PTSD comorbid with TBI. An elevated circulating level of the pro-inflammatory cytokine IL-6 was the most consistently replicated blood-based indicator of comorbid illness, compared to mTBI alone. Conclusion: Several genetic and protein markers of cellular injury and inflammation appear to be promising indicators of chronic pathology in comorbid TBI and PTSD. Additional research is needed to determine how such factors indicate, predict, and contribute to comorbidity and to what extent they represent viable targets for the development of novel diagnostic tools and therapeutic interventions.
Keywords: biomarker, PTSD, TBI, military, veteran, neurodegeneration, genetic, Inflammation
Received: 23 Sep 2024; Accepted: 06 Jan 2025.
Copyright: © 2025 Cowansage, Nair, Lara-Ruiz, Berman, Boyd, Milligan, Kotzab, Bellanti, Shank, Morgan, Smolenski, Babakhanyan, Skopp, Evatt and Kelber. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Marija S. Kelber, Psychological Health Center of Excellence, Defense Health Agency, Silver Spring, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.